Evidence
Evidence-based software as medicine
We research continuously, to keep improving a therapy built on the guidelines.
Used most days, well beyond the first month
How often do patients use Noctua Care?
Guideline alignment
Our therapies build on the accepted guidelines for lowering risk through behavioral and lifestyle therapy.
European Society of Cardiology
The modules follow ESC guidance on secondary prevention: treatment, physical activity, diet, mental health. Every goal the program sets corresponds to a target those guidelines name.
Clinical review throughout
Every module is built with physicians and nursing staff, and reviewed by a cardiologist before it ships.
Studies and development status
What is Noctua Care studying next?
Completed
Content audit
Every module in the program reviewed by CHU Bordeaux.
Completed
Behavioral science engine
Built with the EVIDANS team at CHU Bordeaux.
Completed
DiSuACS engagement trial
Evaluation of the Feasibility of a Digital Support for Patients after Acute Coronary Syndrome. 30 patients over 30 days. Endpoints: usability and engagement. Health Data Hub registration 30001700.
Q3 2026
Quantitative analysis
Behavior change actually implemented after the pilot trial.
Q1 2027
Exploratory randomized trial
200 patients at CHU de Bordeaux and CH de Pau, evaluating the medical impact of the behavior change program.
Pipeline
Noctua Care can target any cardiometabolic disease, symptom or side effect with an underlying neurological or behavioral component.
Coronary artery disease
Phase 3: Pivotal/Reg
Acute coronary syndrome
Phase 2: Dev/Pilot
Peripheral artery disease
Phase 1: Discovery
Atrial fibrillation
Phase 1: Discovery
Heart failure
Phase 1: Discovery
- 1Patients supported: internal data, August 2026.
- 2Usage: DiSuACS, Health Data Hub registration 30001700, single-arm feasibility study, CHU Bordeaux, 2026. n=30, observed over 30 days.
- 3Recommendation: patient survey, 2026.
- 4Google Play rating: read from the app listing, August 2026.